SMITH & MOSESNYS Legislation Tracker

Bills Members Transcripts Hearings

Bills Members Floor Hearings

S5439 | Designates Xylazine as a schedule III depressant | Smith & Moses

S5439SenateCompanion: A5914

Official Title

Designates Xylazine as a schedule III depressant

2023-2024 SessionJames SkoufisAffects: Public Health Law

Status

In Senate Committee

Health

Impact Rating

Unable to calculate

Passage Likelihood

Unable to calculate

Bill Progress

✓

Introduced

👥

In Committee

✅

Committee Passed

📋

Floor Calendar

🏛️

Passed Chamber

🔄

Other Chamber

✓

Introduced

👥

In Committee

✅

Committee Passed

📋

Floor Calendar

🏛️

Passed Chamber

🔄

Other Chamber

What's Happening

Why It Matters

Waiting for summary...